Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease-Reference-Cited by-同舟云学术

Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease

Published:2016-11-18 Issue:1 Volume:17 Page:31-47
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Verstockt Bram¹²,Van Assche Gert¹³,Vermeire Séverine¹³,Ferrante Marc¹³

Affiliation:

1. Translational Research in Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium

2. Department of Medicine and Cambridge Institute for Medical Research, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK

3. Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1258399

Reference100 articles.

1. Unravelling the pathogenesis of inflammatory bowel disease

2. Predicting the Course of IBD: Light at the End of the Tunnel?

3. The immunological and genetic basis of inflammatory bowel disease

4. Anti–Interleukin-12 Antibody for Active Crohn's Disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases;Autoimmunity Reviews;2024-06

2. Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis;Immunity, Inflammation and Disease;2023-10

3. Intestinal Immune Imbalance is an Alarm in the Development of IBD;Mediators of Inflammation;2023-07-31

4. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease;Nature Reviews Gastroenterology & Hepatology;2023-04-17

5. Elevated Serum Interleukin-17 Levels in Thoracic Trauma Patients with Poor Prognosis: A Prospective Observational Study;Clinical and Investigative Medicine;2022-12-31